- Citations, last 5 years
- 147
- Works, last 5 years
- 23
- h-index
- 64
- Scientists listed
- 3
- Grants since 2016
- 21
Grants received
2024–2025 · research · R43
Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease
Jarryd Matthew Campbell · Recombinetics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development
Derek Matthew Korpela · Recombinetics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
A Swine Model of Glioblastoma
Adrienne Leigh Watson · Recombinetics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Swine model of monogenic diabetes with potential implications for T1D, T2D, and double diabetes
Adrienne Leigh Watson · Recombinetics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Development and Characterization of a Preclinical Swine Model of Osteogenesis Imperfecta
David R Deyle · Recombinetics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Development and Evaluation of a Thrombospondin 2 Deficient Pig as an Improved Source of Biomaterial
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2024 · cooperative agreement · U24
SCGE Disease Models Studies Supplement: Evaluation of prime editing for the amelioration of alpha-1-antitrypsin deficiency in murine and porcine models.
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2023 · cooperative agreement · U24
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2023 · cooperative agreement · U24
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2024 · cooperative agreement · U24
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2023 · cooperative agreement · U24
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2018–2023 · cooperative agreement · U24
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Development of a genetic swine model of non-alcoholic steatohepatitis (NASH) by gene-editing
Tamene Melkamu · Recombinetics (United States) · funded by National Institutes of Health
2017–2020 · research · R43
Development of swine model of COPD by integrating genetic and environmental risk factors
Tamene Melkamu · Recombinetics (United States) · funded by National Institutes of Health
2016–2019 · research · R43
Development and Characterization of a Swine Model of Neurofibromatosis Type 2
Adrienne Leigh Watson · Recombinetics (United States) · funded by National Institutes of Health
2016–2019 · research · R43
A Humanized Swine Model for Alzheimer's Disease
Adrienne Leigh Watson · Recombinetics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene Editing
James Richard Goldenring · Recombinetics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Development and Characterization of a Swine Model of Phenylketonuria
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2014–2021 · research · R44
Development of a porcine model of polycystic kidney disease by multiplex gene-editing.
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2014–2020 · research · R44
Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health
2014–2021 · research · R44
Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells
Daniel Fred Carlson · Recombinetics (United States) · funded by National Institutes of Health